background

Filter By Category

Active Pharma Ingredients
Disease Dictionary

Archives

Posted by -

Active Pharma Ingredients / 25 Aug 2026

ANCROD

Generic Name: ANCROD

ABSTRACT -

Ancrod is a thrombin-like serine protease purified from the venom of the Malayan pit viper. It reduces circulating fibrinogen by cleaving fibrinopeptides and has been investigated as a defibrinogenating anticoagulant in vascular and stroke settings.

DOSAGE - 

  • Dosage should be determined only by a qualified healthcare professional.
  • Ancrod is not marketed as a routine approved therapy in most regions.
  • Historical clinical protocols used carefully monitored parenteral dosing.
  • Fibrinogen levels, coagulation tests, and bleeding status must be monitored closely.

SIDE EFFECTS–

  • Possible side effects include:
  • Bleeding
  • Hypofibrinogenemia
  • Injection or infusion reactions
  • Headache
  • Nausea
  • Thrombocytopenia
  • Hypotension
  • Allergic reactions

ALLRGIC REACTIONS–

  • Possible allergic reaction symptoms include:
  • Rash
  • Urticaria
  • Angioedema
  • Bronchospasm
  • Anaphylaxis-like reaction
  • Important: Patients who develop an allergic reaction to Ancrod should seek immediate medical attention and inform all future healthcare providers of the allergy.

DRUG INTERACTIONS–

  • Anticoagulants, antiplatelets, and thrombolytics can markedly increase bleeding risk.
  • NSAIDs may increase bleeding risk.
  • Hemostatic agents may counteract or complicate effects.
  • Recent surgery or invasive procedures increase danger.
  • Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.

PREAUTIONS–

  • Use only where coagulation monitoring and emergency blood-product support are available.
  • Avoid in active bleeding, major trauma, recent surgery, or high hemorrhage risk unless specifically justified.
  • Monitor fibrinogen and neurologic status in stroke research.
  • Screen for venom/protein allergy risk.

WARNINGS –

  • Serious or fatal bleeding can occur.
  • Not for unsupervised use.
  • Do not combine with other anticoagulants unless protocol requires it.
  • Keep out of reach of children.

Have any questions? or Need help Contact us – 022 6163 6163 | support@medicus.com

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2026 Copyright. All rights reserved. Powered by . Developed by Hats-Off

Log in with your credentials

Forgot your details?

Feedback